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COMPARISON OF DOSE-DEPENDENT OUTCOMES IN INDUCTION OF CYTOGENOTOXIC 
RESPONSES BY NOVEL GLUCOSYL FLAVONOIDS 
 
The flavonoids quercetin, and its glucosides isoquercetin and rutin, are phytochemicals 
commonly consumed in plant-derived foods. They are associated with potential health-
promoting effects such as anti-inflammation, anti-viral, anti-carcinogenesis, neuro- and cardio-
protection, etc. Semi-synthetic water soluble quercetin glucosides, maltooligosyl isoquercetin 
(MI), monoglucosyl rutin (MO) and maltooligosyl rutin (MA) were developed to overcome 
solubility challenges for improved incorporation in food and medicinal applications. Quercetin 
and its glucosides are known to induce genetic instability and decrease cell proliferation, which 
are possible mechanisms of anti-carcinogenesis in in vitro and animal studies. Using an in vitro 
system of Chinese hamster ovary (CHO) cells, this thesis project examined the differences in 
cytogenotoxic responses induced by natural and novel flavonoids. Treatments with flavonoids at 
a concentration range of 0.1 and 1,000 ppm induced sister chromatid exchanges (SCE) and 
micronuclei (MN) in CHO cells. Compared to spontaneous occurrences, significant increases in 
SCE and MN were observed in both natural and synthetic flavonoid-treated cells in a dose-
dependent manner. The natural flavonoids exhibited greater potency than the synthetic 
compounds, where quercetin was most potent. An analysis of the effects of flavonoids on DNA 
repair via the poly(ADP ribose) polymerase (PARP) pathway using ELISA showed that all three 
natural flavonoids along with MI and MO were capable of inhibiting PARP activity by 50%. 
Quercetin was observed to be the strongest natural inhibitor of PARP. In growth studies using 
the same treatment dosages as the SCE-MN experiments, colony formation data corroborate 
those of the growth inhibition studies, in which all flavonoids exerted varying inhibitory effects on 
cell proliferation. These cytogenetic studies demonstrated that quercetin, isoquercetin and rutin 
generally exerted more potency than the synthetic compounds, requiring lower doses to achieve 
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efficacy. The ability of both the natural and the synthetic flavonoids to cause genomic instability 
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Flavonoids are naturally occurring polyphenolic compounds ubiquitous in plants, where 
they serve a multitude of physiological functions [1-2].  In plants, flavonoids neutralize oxidative 
stress, regulate growth, deter feeding by herbivores, and provide protection against pathogens 
[2-3]. These compounds contribute to the bright hues of yellow, orange, red and blue, in foliage, 
flowers and fruits [4]. Flavonoids are common constituents in the human diet as they are 
consumed in plant-derived foods and beverages, such as fruits, vegetables, tea, cocoa, and 
wine [5-6]. In food applications, these compounds are used as coloring agents, flavor enhancers 
and antioxidants [7]. In the United States, typical consumption of dietary flavonoids is 
approximately 1 g/day, while intake fluctuates with geography, seasons, and individual 
preference [8-9].  
All flavonoids share a common benzo-γ-pyrone molecular core which comprises 15 carbon 
atoms arranged in three rings (Fig. 1) [1]. Classes of flavonoids are organized by the oxidation 
and substitution patterns of the heterocyclic C ring, whereas compounds within a class are 
distinguished by the substitution patterns on the A and B rings (Fig. 1) [10]. The variations in  
 




oxidation levels and substitution patterns have led to the identification of over 4,000 flavonoid 
compounds and characterization of five major classes [10]. Flavone, flavanone, isoflavanone, 
flavonol, and flavan-3-ols make up the major classes of flavonoids (Table 1). A contributing 
factor to the great variety of flavonoids is that these polyphenolic compounds occur as 
aglycones, glucosides1, and methylated derivatives [7]. Glucosides tend to form on the 
glucosidic linkage at positions 3 or 7 (Fig. 1), where the carbohydrate is often glucose but can 
also be rhamnose, glucorhamnose, galactose, or arabinose [11]. Some common food sources 
associated with various classes of flavonoids are shown in Table 2. Quercetin, catechin, and 
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1.2 Biological Properties 
In plants, the biological properties of flavonoids have been well established. As 
photoreceptors, they regulate auxins, a class of hormones responsible for growth and 
differentiation, through stimulation, or inhibition [18,19]. The pigments of flavonoids are often 
reflected in plant foliage and flowers where they influence the feeding behaviors of pollinators 
[20]. Flavonoid compounds have an unpleasant taste which contributes to plant defense against 
herbivores [3,20]. They also provide protection against pathogens by inhibition or crosslink of 
microbial enzymes essential to proliferation [21]. Furthermore, flavonoids serve as UV screens 
by absorbing UV radiation and shielding plants from damage to internal tissues [22]. The best 
known physiological property of flavonoids in plants is antioxidation. Flavonoid compounds can 
be induced in response to oxidative stress, brought on by metabolic processes, or 
environmental stress, as well as, depletion of antioxidant enzymes [23]. Oxidation occurs when 
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the electron transport chain becomes uncoupled, resulting in the transfer of unpaired single 
electrons from one atom to another [2]. The outcome of this process is the generation of free 
radicals, which are also known as, reactive oxygen species (ROS). Common examples of ROS 
include superoxide (O2˙
‾), hydroxyl radical (OH˙), hydrogen peroxide (H2O2), peroxynitrite  
(ONOO‾), and nitric oxide (NO˙). Under normal conditions, eukaryotic organisms manage ROS 
with a system of endogenous antioxidant enzymes [24]. However, when an imbalance of ROS 
production and radical scavenging activities arises through depletion of antioxidant enzymes, 
oxidative stress occurs [24]. Accumulation of ROS damages lipids, proteins, nucleic acids, and 
tissues [24].  
Flavonoids combat oxidation with diverse mechanisms. They scavenge free radicals and 
arrest initiation of lipid peroxidation, and chelate transition metals [25]. Chelated metals are 
removed as electron donors from the process of reactive oxygen species (ROS) formation via 
the Fenton reaction. Flavonoids inhibit oxidases, catalysts of superoxide radical production, 
through their molecular configuration and hydroxylation patterns [26]. Reduction of alpha-
tocopherol radicals via hydrogen donation by flavonoids is another major antioxidative 
mechanism [27].  The protective antioxidant effects in plants yield potentially significant health 
benefits in humans and are the focus of research in the medical, pharmaceutical, and food 
industries.  
 
1.3 Human Health and Therapeutic Implications  
 The concept of the French paradox, in which epidemiological studies highlighted 
historical consumption of diets high in saturated fat and a low occurrence of cardiovascular 
disease in the French population, generated immense interest in flavonoids [28]. The paradox 
was attributed to large consumption of fruits and vegetables on top of high saturated fat intake 
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[29]. Following the French paradox, a surge of extensive investigations into possible beneficial 
health effects consequent to flavonoid-rich diets and supplements resulted in in vitro, in vivo, 
and epidemiological evidence, which suggests a myriad of benefits (Fig. 2). Flavonoids have  
 
                
                Figure 2 Protective health benefits associated with flavonoids. 
 
 
been shown to impede development of atherosclerosis by inhibiting oxidation of low-density 
lipoprotein (LDL) [31]. Catechins which are found in tea, may delay the development of 
atheromatous lesions in arterial walls by inhibiting invasion of smooth muscle cells [32]. 
Resveratrol, a prominent flavonoid in wine, inhibits activities of cyclooxygenase 1, which 
subsequently, prevents platelet aggregation [33]. Quercetin, the most abundant flavonoid, 




Flavonoids, such as quercetin, resveratrol, flavanones, isoflavones, and catechins have 
demonstrated chemopreventive effects in numerous studies. Carcinogenesis is a multi-phase 
process, characterized by three distinct phases: initiation, promotion, and progression. Initiation 
involves genetic alteration, whereas, promotion requires non-genetic stimului to trigger cell 
proliferation. The sequence of initiation and promotion events can lead to progression to 
malignancy. Flavonoids exert chemopreventive effects that interfere with various stages of 
carcinogenesis through a variety of mechanisms. Cell cycle arrest and apoptosis are anti-
proliferative and anti-angiogenic; induction of detoxification enzymes prevent oxidative stress 
and inflammation; alteration of cellular signaling and immune system regulation contribute to 
anti-tumorigenic activities [30]. The catechin flavonoid, theaflavin interferes with metastasis in 
human breast cancer cells via p53 downregulation of the metastatic proteins, metalloproteinase 
2 and 9 [35]. The soy-based isoflavone, genistein induces cell cycle arrest of human breast 
cancer cells at physiologically relevant concentrations [36]. In mice, quercetin is shown to 
protect against lung cancer induced by benzo(a)pyrene through its radical scavenging 
mechanism [37]. Resveratrol was found to induce apoptosis through activation of the caspase 
cascade in human pancreatic cancer stem cells [38]. 
Anti-viral activities have been reported in studies which explored flavonoid treatments 
against infections. Theaflavins, common flavonoid constituents in black tea, were found to 
protect against infections from the human immunodeficiency virus (HIV) by preventing formation 
of the viral helix bundle necessary for fusion with the host cell membrane [39]. Analogs of 
theaflavins have exhibited anti-viral activities against the corona virus responsible for Severe 
Acute Respiratory Syndrome (SARS) [39]. The protective effect is attributed to disruption of the 
viral replication process via inhibition of proteolytic processing [39]. Protection from 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases may be associated 
with consumption of flavonoids. In rat studies, rutin, a flavonoid abundant in buckwheat and 
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wine, was shown to improve memory retrieval through protective activity from β-amyloid toxicity, 
a key factor in Alzheimer’s disease [40]. Nobiletin, a citrus peel flavonoid, exhibited 
enhancement of dopamine release resulting in improved motor functions in rodent models of 
Parkinson’s disease [41]. 
Diabetes mellitus, a disease indicated by hyperglycemia due to defective glucose 
metabolism, is associated with long term progressive health complications when the disease is 
not maintained. Impaired immunity, retinopathy, neuropathy, nephropathy, and cardiovascular 
conditions are serious complications of diabetes, which can be debilitating and life threatening 
[30]. Epigallocatechin gallate (EGCG), a flavan-3-ol flavonoid, has expressed anti-diabetic 
activities in in vitro and animal studies [42]. Under glucotoxic conditions, EGCG promoted 
insulin release through upregulation of insulin receptors, and survival of pancreatic β-cells by 
modulating oxidative stress and cytokine-induced apoptosis through inhibition of pro-apoptotic 
proteins [42]. Kaempferol, a flavonol, was also shown to promote cell survival under cytotoxic 
conditions by rescuing β-cells and pancreatic human islet cells from lipid peroxidation-induced 
apoptosis [43].  
Extensive evidence provides a rationale in support of using dietary flavonoids in the 
prevention of various diseases, in conjunction with either conventional drug therapy, or dietary 
intervention. Although solubility may pose hindrance to therapeutic efficacy as most flavonoids 
are poorly solubilized in water [7,44]. This limitation can be attributed to the crystalline structure 
of the flavonoid compounds, which exerts strong intermolecular forces that cannot be broken by 
the release of energy during solvation [44]. The solubility issue has been circumvented to an 
extent by the development of partially synthetic flavonoids with increased water solubility [44]. 
However, the low solubility property of flavonoids restricts bioavailability, and consequently, 
toxicity from consumption [7].  
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1.4 Bioavailability of Flavonoids in Humans 
 The implications of flavonoid therapeutic value appear to be diverse, but in order to 
optimize the health benefits, the bioavailability of flavonoid compounds must be considered. The 
physicochemical properties of flavonoids dictate absorption from either the small intestine or the 
colon [3]. Aglycone flavonoids are freely absorbed by the small intestine, while hydrolysis of 
glucosidic flavonoids is required for transformation to aglycones prior to absorption [45-47]. 
Preferential flavonoid glucoside hydrolysis takes place in the lumen of the small intestine via β-
glucosidases [45-47]. Glucosides without substrates specific to β-glucosidases are hydrolyzed 
by microflora in the colon, where absorption capacity is much more limited, and free aglycones 
are degraded [45-47]. Once absorbed, flavonoids are metabolized in the liver to phenolic acids 
or conjugated to glucuronides, sulfates, or methylated compounds [3]. The metabolites are 
primarily excreted in feces, with a small fraction in urine [3]. Figure 3 summarizes flavonoid 
metabolism in humans. Hydrolysis is essential to the absorption of flavonoid glucosides, but it is 
one of several factors that determine bioavailability. The sugar moiety of glucosides, as well as, 
functional groups on the molecular core influences the structural and physiological location of 
hydrolysis [48-49]. Dose, delivery vessel, diet, gender differences, and colonic microflora 




             
          Figure 3 Simplified scheme of flavonoid metabolism. Reference: [3]. 
 
 
1.5 Quercetin and its Glycosides 
1.5.1 Quercetin, Isoquercetin and Rutin 
 Quercetin is the most abundant flavonol, a subclass of flavonoids, which occurs in nearly 
all parts of fruits and vegetables [18]. Quercetin-rich dietary sources are cranberries, apples, 
blueberries, onions, black tea, red wine, and fruit juices [50]. The average daily intake of 
quercetin is estimated to be in the range of 25 mg to 500 mg per day, which makes up 
approximately 2.5% to 50% of the estimated total consumption of flavonoids per day [9]. In 
plants, quercetin commonly occurs as glycosides, such as isoquercetin and rutin. Isoquercetin 
and rutin each has a monosaccharide and a disaccharide residue on the glycosidic linkage, 
respectively (Fig. 4). Isoquercetin is widely distributed in mangoes, apples, and a variety of fruits 
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and vegetables [51]. Buckwheat, citrus fruits, fruit skins, and red wine are typical sources of 
rutin [52].    
 
      Figure 4 Molecular structures of quercetin and its glycosidic derivatives. 
 
Similar to reported benefits of many flavonoids, studies in cell systems and animals 
show that these flavonols are potentially beneficial to human health [53-59]. Quercetin has been 
shown to be cardioprotective through reduction of oxidative stress associated with ischemia and 
reperfusion [53]. It is reported to modulate inflammation by decreasing production of 
inflammatory cytokines [54]. The anti-proliferative effects of quercetin have been demonstrated 
in various types of cancer cells including breast, cervical, gastric, and skin [5,55-57]. 
Isoquercetin has exhibited neuroprotective effects against lipid peroxidation in neurotoxic 
induction of Parkinson’s disease, and oxidative stress produced by ischemic brain injury [51,58]. 
Anti-allergenic and anti-arthritic activities have been expressed by rutin. Rutin was shown to be 
effective in inhibiting histamine release during immunoglobulin E-mast cell activation in mucosal 







Following ingestion, quercetin is primarily absorbed and metabolized in the small 
intestine [18,50]. However, the only form of quercetin that can be absorbed is as an aglycone 
[18,50]. The glycosides, isoquercetin and rutin, must undergo hydrolysis and transformation to 
the quercetin aglycone in either the small intestine or the colon [7,50]. The aglycone is 
transported into enterocytes via sodium-dependent glucose transporters, where it is methylated, 
glucuronidated, or sulfated at one of the hydroxyl sites on the aglycone [50]. Conjugated and 
free quercetin then enter systemic circulation via the hepatic portal vein [50]. Once in the liver 
and kidney, the metabolites and untransformed quercetin can be further metabolized by 
methylation, sulfation and glucuronidation [18,50]. Unabsorbed quercetin glycosides and free 
quercetin are subject to metabolism and degradation by colonic microflora to phenolic acids and 
carbon dioxide [18,50]. Rodent studies indicate that a mere 3% of quercetin aglycone is 
absorbed from the colon [50]. Animal and human studies suggest that up to 60% of the ingested 
dose is absorbed and bioavailable [50]. Systemic distribution of quercetin affects all organs and 
tissue types [50]. The majority of quercetin metabolites is excreted in feces and respired, with 
urine as a minor elimination pathway [18,50]. Human studies have reported the elimination half-
life of quercetin to be in the range of 31 – 50 hours [50]. 
1.5.3 Pharmacodynamics 
The health benefits linked to quercetin, isoquercetin and rutin are generally associated 
with their antioxidant properties [18,51,58]. The antioxidant property of these flavonols is largely 
attributed to their chemical structure which has a hydroxylation pattern of 3, 5, 7, 3’, and 4’, and 
a catechol B ring (Fig. 4) [60]. Bors and colleagues characterized an antioxidant as having a 
catechol group in the B ring, a 2,3-double bond, and hydroxyl substitutions at positions 3 and 5 
[61]. These features take part in the radical scavenging and metal chelating activities of 
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flavonoids [62]. Quercetin preferentially chelates transition metals, such as iron and copper, at 
C3-OH, C4=O, C5-OH, and the catechol moiety [62]. Metal chelation prevents oxidative stress 
through removal of transition metals from the Fenton reaction, where their presence in a low 
oxidation state with hydrogen peroxide produces hydroxyl radicals [62]. 
Quercetin also has pro-oxidant properties that are rooted in the same structural 
attributes which give rise to its antioxidant properties. It can be metabolically bioactivated to the 
reactive products, semi-quinone intermediate, and subsequently, ortho-quinone. Ortho-quinone 
can bind DNA causing oxidative damage, which is proposed to be a mechanism of mutagenicity 
of quercetin. The mutagenic property of quercetin has been well established in positive reverse 
mutation tests in various strains of Salmonella typhimurium, though it has not exhibited 
carcinogenic effects in humans [3,16]. Such mutagenic property may confer protection against 
carcinogenesis [64]. Glycosylation of aglycones, on the other hand, tends to diminish pro-
oxidant activities, resulting in less mutagenicity [64].    
Genetic stability is crucial to cell proliferation and survival, and as a mutagen, quercetin 
has been shown to induce genomic instability in the form of sister chromatid exchange (SCE) 
and micronuclei [65]. It was also demonstrated to impair DNA repair capability by inhibiting 
poly(ADP ribose) polymerase (PARP), an enzyme critical to DNA single strand break (SSB) 
repairs, in various cancer cell lines [5]. Aside from causing genomic instability, quercetin has 
exhibited cytotoxicity through growth inhibition and cell cycle arrest in various types of cancer 
cells [7]. Collectively, these anti-proliferative mechanisms make quercetin and its glycosides 






1.6 Statement of Project 
Quercetin and its glucoside derivatives have demonstrated potential health benefits and 
therapeutic value in in vitro and animal studies. Increased consumption of these dietary 
flavonols may provide protection against various diseases, particularly cancer. However, the 
poor water solubility property of quercetin poses an issue in manufactured food and beverage 
applications, which has led to the development of semi-synthetic versions of this compound. 
This thesis is an examination of the cytogenotoxic responses induced by three novel glucosyl 
flavonoids, in comparison to those of quercetin, isoquercetin, and rutin. Using known 
cytogenotoxic endpoints of quercetin, an analysis of growth inhibition, viability, sister chromatid 
exchange, micronuclei, and inhibition of PARP activity was completed in an in vitro system of 














Comparative Studies of Cytogenotoxic Effects of Natural and Synthetic Flavonoids: 
Quercetin, Isoquercetin and Rutin versus Maltooligosyl Isoquercetin, Monoglucosyl 
Rutin and Maltooligosyl Rutin. 
 
2.1 Background and Rationale 
As human health stands to benefit from the biological properties of quercetin and its 
glycosides isoquercetin and rutin, there is an increase in interest to incorporate these flavonols 
into various food and beverage products, as well as, therapeutic applications. Before these 
flavonol compounds can be employed in food and therapeutic applications, the challenge of 
water solubility must be overcome. Quercetin, isoquercetin and rutin are not readily miscible 
with water which lends difficulty to their incorporation into dietary products, and utilization in 
medicinal applications [7]. The miscibility issue has led to the development of semi-synthetic 
flavonoid glycosides with improved water solubility: maltooligosyl isoquercetin (MI), 
monoglucosyl rutin (MO), and maltooligosyl rutin (MA) (Fig. 5). Enzymatic modifications to the 
natural aglycone and glycosides increase the number of carbohydrates that are attached to the 
glycosidic linkage of the novel glycosides. MI and MA contain one to seven glucose 
modifications, and only a single glucose modification on MO.   
 Currently, no cytogenotoxic information is available for MI, MO and MA. The aim of this 
thesis is to examine the cytogenetic responses through comparison of known cytogenotoxic 
endpoints induced by quercetin with those of the novel glucosyl flavonoids. Endpoints under 
evaluation are cell viability and growth inhibition, SCE, micronuclei, and PARP inhibition. It is 
hypothesized that the novel glucosyl flavonoids will mimic the cytogenotoxic effects exhibited by 
quercetin in a dose-dependent manner, based on similarities in structural composition of these 
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compounds. Using a system of wild-type CHO cells, treatments with reconstituted flavonols at a 
concentration range of 0.1 – 10,000 ppm were applied to CHO cell cultures in viability, growth, 
SCE and micronuclei assays. PARP activity was determined using ELISA and the same 
treatment dosages.  
 








2.2 Materials and Methods 
2.2.1 Cell culture 
CHO cells were cultured and maintained in minimum essential medium (MEM-α, Gibco, 
Grand Island, NY) and supplemented with 10% fetal bovine serum (FBS, Sigma, St. Louis, MO) 
and 1% antibiotics and antimycotics (Gibco, Grand Island, NY) in a humidified incubator at 37oC 
and 5% CO2.  
2.2.2 Flavonoids 
Quercetin, isoquercetin, maltooligosyl isoquercetin, rutin, monoglucosyl rutin and 
maltooligosyl rutin were provided by the Toyo Sugar Refining Co., Ltd. (Tokyo, Japan). 10% 
(w/v) solutions of all flavonoids were prepared in dimethyl sulfoxide (DMSO, Fisher Scientific, 
Pittsburgh, PA). The treatment dosage range utilized in this study was 0.1 ppm to 10,000 ppm.  
2.2.3 Colony formation 
Trypsinized CHO cells were plated on P-60 dishes to obtain approximately 100 colonies 
per dish. Cells were treated with various dosages of natural and synthetic flavonoids. After a 7-
day incubation period, cells were washed in 0.9% sodium chloride and fixed in 100% ethanol, 
then stained with 0.1% crystal violet dye (Sigma). Colonies with greater than 50 cells were 
recorded as viable. 
2.2.4 Growth inhibition 
In 24-well plates, 4,000 CHO cells were seeded per well, then treated with various 
dosages of flavonoids, and incubated for 3 days. Trypsinized cells were counted using the 




2.2.5 PARP inhibition 
PARP colorimetric assay kits (Trevigen, Gaithersburg, MD) were used to measure PARP 
activity. PARP was incubated in a 96-well microplate with a reaction mixture containing 50 μM 
β-NAD+ (10% biotinylated β-NAD+), 90% unlabeled β-NAD+, 1 mM 1,4-dithiothreitol and 1.25 
mg/l nicked DNA. The formation of poly(ADP-ribose) polymers was detected with peroxidase-
labeled streptavidin and 3,3',5,5'-tetramethylbenzidine (Invitrogen, Carlsbad, CA). PARP 
inhibition was assessed by the addition of flavonoids at various dosages to the reaction mixture. 
PARP activity is directly proportional to absorbance at 450 nm and measured by the NanoDrop 
spectrophotometer (Thermo Fischer Scientific, Waltham, MA).  
2.2.6 Sister chromatid exchange 
CHO cells were synchronized into G1 phase using a mitotic shake-off procedure [66]. 
Synchronized mitotic cells were sub-cultured in T25 flasks and incubated for two hours at 37°C. 
Cells were treated with various concentrations of flavonoids and incubated with 10 uM of 5-
bromo-2’-deoxyuridine (BrdU, Sigma) for two cell cycles. 0.2 μg/ml of colcemid (Gibco) was 
added to cells and allowed to incubate for an additional 6 hours. Cells were harvested during 
metaphase, trypsinized and then suspended in 4 ml of a 75 mM KCl solution warmed to 37°C 
and placed in a 37°C water bath for 20 minutes. A fixative solution of 3:1 methanol to acetic acid 
was added to the samples according to the standard protocol [67]. Fixed cells were dropped 
onto slides and allowed to dry at room temperature. Differential staining of metaphase 
chromosomes was completed using the fluorescence plus Giemsa (FPG) technique [68]. 
Differentially stained metaphase chromosome images were taken using a Zeiss Axioplan 
microscope equipped with Q-imaging Aqua CCD camera and Q-capture Pro software. A 
minimum of 50 metaphase cells were scored for each treatment concentration. Data presented 




G1 synchronized CHO cells were incubated with various concentrations of flavonoids 
and 8 ug/ml of Cytochalasin B (Sigma) for 22 hours. Harvested cells were suspended in 5 ml of 
75 mM KCl solution, centrifuged, and fixed in 3:1 methanol:acetic acid solution and 
formaldehyde (Fisher Scientific). Cells were dropped onto slides and allowed to air dry at room 
temperature. Slides were stained in 10% Giemsa (Gibco) in GURR (Gibco) solution for 5 
minutes. 300 binucleated cells (BNC) were scored per treatment dosage, and images were 
analyzed using a Zeiss Axioplan microscope. 
2.2.8 Statistics 
All experiments were repeated at minimum three times, and error bars indicate standard 
errors of the means. Statistical significance was assessed by the t test using Prism 5 software 




2.3.1 Cell viability and growth inhibition 
Assessment of cell viability was based on qualitative colony formation and quantitative 
growth curve studies. Figure 6a shows the effect of 1 and 10 ppm quercetin treatments 
compared to the control sample, where a reduction in the number and size of colony formations 
was observed. The effects of rutin, MO and MA treatments are shown in Figure 6c. The colony 
size and formations decreased with increasing concentrations when compared to the control. 
Isoquercetin and MI also exerted effects with similar trends as quercetin and rutin (Fig. 6b). No 
colony formations were observed at the 1,000 ppm treatment dose for all flavonoids, except for 
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MA, where very small colonies formed. Growth curve studies show that quercetin is the most 
potent in growth inhibition with an extrapolated IC50 (concentration at which 50% activity is 
inhibited) of 5 ppm, where isoquercetin and MI had an IC50 of 200 ppm (Fig. 7a). The IC50 of 
rutin is 500 ppm and MO 2,000 ppm, while MA does not reach IC50 at the highest dose of 1,000 




Figure 6 Effects of flavonols on CHO cell colony formations 10 days post treatment: (a) 








Figure 6 continued Effects of flavonols on CHO cell colony formations 10 days post 





Figure 7 Growth curves of CHO cells in response to treatments with flavonoids after 3 
days: (a) quercetin, isoquercetin and MI over a treatment range of 0.1 to 1,000 ppm; (b) 






2.3.2 Sister chromatid exchange 
The frequency of SCE was determined through incorporation of BrdU into DNA during 
cell replication, followed by the arrest of cells in metaphase, chromosome extraction, and 
differential staining of chromosomes. Figure 8 illustrates images of SCE in metaphase 
chromosomes. Figure 9 shows SCE induction frequency per chromosome. Untreated CHO cells 
exhibited a mean background level of 0.21 SCE per chromosome. Figure 9a shows the SCE 
frequency in cells treated with 0.1 – 10 ppm quercetin, isoquercetin and MI. All three 
compounds induced SCE at a range of 0.22 – 0.27 SCE per chromosome. Isoquercetin induced 
the largest and significant SCE frequency of 0.27 per chromosome at 1 ppm (p<0.05). While 
quercetin induced slightly less SCE frequency of 0.26 per chromosome at 0.1 ppm, and the 
increase is significant (p<0.05), which makes it more potent than isoquercetin and MI. The SCE 
induction frequency by MI is the same as that of quercetin, though this increase required 10 
ppm to achieve the same response. No SCE was observed at doses above 10 ppm for these 
three flavonoids. 
Rutin, MO and MA also induced SCE responses across all three doses of 1, 10, and 100 
ppm (Fig. 9b). Treatments with 0.1 ppm were not used in this study based on previous 
screenings, which did not result in responses above spontaneous background levels of SCE. 
Rutin, MO and MA induced SCE frequencies at a range of 0.19 – 0.26 per chromosome. Of 
these three, rutin exerted the most potency with a significant SCE frequency of 0.26 per 
chromosome at 1 ppm (p<0.05). Rutin maintained its potency at 10 ppm with a slightly less but 
significant SCE frequency of 0.25 per chromosome (p<0.05). MO achieved the same response 
of 0.26 SCE frequency per chromosome (p<0.05) as rutin, but at 100 ppm. MA treatments did 
not result in statistically significant responses. No SCE was observed at treatments with 1,000 
ppm for rutin, MO and MA. Based on order of potency demonstrated in this study, the flavonoids 














Figure 9 SCE frequency per metaphase chromosome after treatment with flavonoids for 
25 hours, (* indicates p<0.05): (a) responses to quercetin, isoquercetin and MI at 0.1, 1, 






Micronucleus frequency was quantified by arresting untreated and treated mitotic CHO 
cells in telophase with cytochalasin B, which resulted in binucleated cells. Untreated cells had a 
background level of 0.01 MN per binucleated cell. An image of a micronucleus in a binucleated 
cell is shown in Figure 10. All flavonoid treatments resulted in varying degrees of MN induction. 
Induced responses by quercetin, isoquercetin and MI range from 0.005 – 0.075 MN per 
binucleated cell (Fig. 11a). Of these three, 10 ppm quercetin resulted in statistically significant 
(p<0.05) and the highest induction of MN frequency at 0.075 MN per binucleated cell (Fig. 11a). 
All four treatment doses of isoquercetin induced significant frequencies of MN (p<0.05), where 
the 1,000 ppm treatment induced 0.06 MN per binucleated cell (Fig. 11a). MN frequencies for 
MI occurred at or below control levels for doses of 1 – 100 ppm, however, at 1,000 ppm, 0.065 
MN per binucleated cell (p<0.05) were observed (Fig. 11a). The frequencies of MN induced by 
rutin, MO and MA range from 0.008 – 0.04 MN per binucleated cell (Fig. 11b). Rutin significantly 
increased MN frequencies at 1 and 1,000 ppm with 0.016 and 0.04 MN per binucleated cell 
(p<0.05), respectively (Fig. 11b). Both MO and MA induced significant frequencies of MN at 100 
ppm, where MO treatment resulted in 0.02 and MA 0.016 MN per binucleated cell (p<0.05) (Fig. 
11b). Similar to the SCE studies, quercetin demonstrated to be the most potent MN inducer. 
The relative potency of each flavonoid is summarized as follows: 
















Figure 11 Frequency of micronuclei per binucleated cell after a 20-hour treatment with 
flavonoids: (a) treatment with quercetin, isoquercetin and MI at concentration range of 1 to 
1,000 ppm; (b) treatment with rutin, MO and MA at concentrations of 1 to 1,000 ppm. Asterisk 
indicates p<0.05.  
 
2.3.4 PARP activity 
Flavonoid influence on PARP activity was quantified using a PARP ELISA assay which 
measured poly ADP-ribosylation of histone proteins. 3-aminobenzamide (3-AB), a known PARP 
inhibitor was used as a positive control. Quercetin exerted the greatest inhibitory effect on 
PARP activity (Fig. 12a) with an extrapolated IC50 of 30 ppm, followed by 3-AB at IC50 of 100 
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ppm. Rutin and isoquercetin share the same IC50 at 1,000 ppm, whereas treatments of 10 and 
100 ppm with both flavonoids show rutin as the stronger inhibitor of PARP (Fig. 12a-b). All three 
synthetic flavonoid glycosides exhibited less inhibitory effects on PARP activity than the natural 
flavonoids (Fig 12a-b). The IC50 for MO is 5,000 ppm, while MI and MA do not reach IC50 even 
at 20,000 ppm (Fig. 12a-b). The apparent potency of each flavonoid in PARP inhibition is 

















Figure 12 Inhibitory effects of flavonols on PARP activity: (a) treatments with quercetin, 
isoquercetin and MI at concentrations of 0.1 to 20,000 ppm; (b) treatments with rutin, MO 
and MA at concentrations of 1 to 20,000 ppm; aminobenzamide is a positive control. 
 
2.4 Discussion 
The results of the present study support the hypothesis that synthetic flavonoids mimic 
the cytogenotoxic responses induced by natural flavonoids. The degree of responses, however, 
appears to be modulated by the structure activity of each flavonol, as determined by the number 
of glucosides contained in each compound. Both the natural and synthetic flavonoids exhibited 
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weakened cytogenotoxic effects in accordance with the level of glycosylation. Based on findings 
in this study, they are ranked as follow in order of overall potency, which also corresponds with 
the number of glucosides: quercetin>isoquercetin>rutin>MI>MO>MA. Quercetin, the aglycone 
flavonol, exhibited the most potency across all cytogenetic assays in this study, requiring the 
lowest treatment dose to induce significantly high frequencies of SCE and MN (p<0.05) and 
effectively inhibit growth and PARP activity. Its poor water solubility property is most likely 
responsible for high bioavailability, since aglycones do not contain glucosides that prevent, or 
require enzymatic hydrolysis for absorption into cells. MA, a manufactured quercetin rutinoside 
derivative with 1 – 7 glucosyl modifications, exerted the least cytogenotoxicity in this study. MA 
did not significantly induce SCE or produce IC50’s in growth and PARP experiments at the 
highest doses. In colony formation assays, MA was the only flavonol which did not completely 
prevent colony formations at the highest treatment dose of 1,000 ppm after 7 days. While a 
significant induction of MN frequency was observed at 100 ppm (p<0.05), MA produced the 
lowest frequency of all the significant observations. These results suggest that MA is 
substantially less bioavailable than other flavonols. As a consequence of having more glucosyls 
and increased water solubility over natural flavonoids, these properties most likely contribute to 
poor absorption into cells, thus reducing bioavailability.  
Consistent with other studies, the high frequencies of SCE and MN indicate that 
quercetin is able to bind DNA, possibly causing oxidative damage through its pro-oxidant 
property that resulted in DNA damage and disruption to DNA repair processes [65,69]. SCE and 
MN occur under different mechanisms, and together, the effects may drastically lower 
chromosomal stability resulting in growth arrest or apoptosis. SCE is a product of DNA 
homologous recombination in response to collapse of the DNA replication fork due to strand 
breaks [70]; whereas MN are fragments of chromosomes, or whole chromosomes that failed to 
be incorporated in the daughter nuclei during nuclear division, as a result of defective DNA 
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lesion repairs or mitotic malfunction [71]. The reduction in cell proliferation evident in the growth 
curves (Fig. 7) and colony formation studies (Fig. 6) may also be attributed to failure to maintain 
genetic stability. PARP is an enzyme crucial to DNA single strand break (SSB) repair, in which 
PARP detects and binds to a site of SSB, then synthesizes poly (ADP) ribose (PAR) proteins; 
PAR recruits other repair proteins to the site of damage to complete DNA repair [72]. Quercetin 
and rutin have previously been reported to preferentially inhibit PARP in BRCA-mutant cells 
associated with ovarian and breast cancers, which subsequently impairs cell viability [5]. In 
agreement with literature on PARP inhibitors, the current study demonstrated that quercetin and 
rutin were both effective in inhibiting PARP activity [5]. Isoquercetin and MO also inhibited 
PARP, although requiring much higher doses than quercetin. While MI and MA decreased 
PARP activity, they did not achieve IC50, even at the highest doses. Studies of PARP-deficient 
cell systems show that exposure to genotoxic chemicals resulted in a substantial increase in 
SCE and MN frequencies, which suggest an increase in recombination repairs [73]. The ability 
of natural and synthetic flavonoids to inhibit PARP indicates that the absence of this enzyme 
may be an underlying factor in the decline in genomic stability of exposed CHO cells. 
Furthermore, PARP has been shown to play a role in proper chromatin conformation of newly 
synthesized DNA [73]. Thus, elevated SCE and MN frequencies induced by flavonoids may 
involve a combination of mechanisms related to PARP inhibition: failure of DNA repair and 
alterations of chromatin conformation. Additionally, PARP is reported to be essential in cell 
proliferation, and its inhibition can negatively affect cell growth through several mechanisms: 
decreased cell recovery after oxidative damage; increased genomic instability from loss or gain 
of chromatin delays proliferation; and failure of the activation cascade of DNA repair proteins 
[73].  
Interestingly, all flavonoids in this study share a common trend, where an inverse 
relationship between dose and responses in induction of SCE is observed. Instead of a dose-
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dependent increase in SCE inductions, SCE frequencies declined at higher treatment doses. 
Examinations of stained chromosomes show a decreased proportion of cells in mitosis to those 
which are not. The lack of SCE responses appears to correspond with impairment of cell 
proliferation and viability. As evident in the growth studies, cell proliferation is impeded by 
increased flavonoid concentrations. Failure at the DNA replication fork must take place in order 
for SCE to form, and when cells cease to divide, SCE are not generated. These observations, 
on the other hand, are generally not expressed in MN inductions with exception of quercetin. 
Quercetin induced a peak MN frequency of at 10 ppm and no responses at 100 and 1,000 ppm. 
These observations may be explained by PARP inhibition, defective DNA repairs, and cessation 
of cell growth, which are evident in the present study. PARP is reported to be important in 
maintaining chromatin conformation, and its inhibition can result in an increase in MN frequency 
[73]. MO and MA induced a peak MN frequency at 100 ppm, although low but significant 
responses; and at 1,000 ppm, the MN inductions reduced to insignificant levels. A low MN 
response at 1,000 ppm following a peak response at 100 ppm, may be attributed to cytotoxicity 
associated with genomic instability. 
The relevance of these findings for potential utilization in food and therapeutic 
applications as a chemopreventive agent is efficacy. This study shows that increased water 
solubility by glucosidic modifications corresponds with reduction in efficacy, which is most likely 
the result of poor absorption. The novel flavonoid glucosides have a large number of 
carbohydrate modifications which require enzymatic hydrolysis for absorption into cells. While 
hydrolysis can transform glucosides to aglycones, the site of cleavage may differ from one 
compound to another [3,7]. Although a flavonoid glucoside is cleaved, it may still retain some 
carbohydrates, preventing its absorption. Utilization of the novel glucosyl flavonoids for the 
purposes of chemoprotection would likely require a higher dose with repeated consumption to 
achieve similar efficacies as quercetin. The completion of this study is only the preliminary step 
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to more in depth cytogenetic studies, as animal studies still need to be conducted and evaluated 






















A comparison of the cytogenotoxic responses induced by the natural flavonoids, 
quercetin, isoquercetin and rutin, and the manufactured flavonoids, MI, MO and MA, show that 
the natural flavonoids exhibited greater cytogenotoxicity than the synthetic flavonoids. It was 
apparent that the cytogenetic effects were modulated by the structure activity associated with 
the level of glycosylation of each flavonoid. An increase in the number of glucosides 
corresponds with a decrease in cytogenotoxic effects. Quercetin, the aglycone demonstrated to 
be most potent, inducing significant responses in all cytogenetic endpoints. It was readily 
absorbed by cells and made bioavailable. The water soluble MI, MO and MA which contain 3 – 
9 glucosyls, induced less cytogenetic effects than the natural flavonoids. The increased water 
solubility property hinders absorption into cells and decrease bioavailability, as these flavonoids 
require enzymatic hydrolysis for conversion to the aglycone form. The relative potency of 
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